STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world

• Norah J. Shire ,

  Roles Conceptualization, Formal analysis, Methodology, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: Norah.Shire@astrazeneca.com

  Affiliation AstraZeneca, Gaithersburg, MD, United States of America

  http://orcid.org/0000-0002-1969-8037

  ⨯
• Alyssa B. Klein,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation AstraZeneca, Gaithersburg, MD, United States of America

  ⨯
• Asieh Golozar,

  Roles Conceptualization, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  Affiliation AstraZeneca, Gaithersburg, MD, United States of America

  ⨯
• Jenna M. Collins,

  Roles Methodology, Project administration, Writing – original draft, Writing – review & editing

  Affiliation Evidera, Waltham, MA, United States of America

  ⨯
• Kathy H. Fraeman,

  Roles Formal analysis, Methodology, Project administration, Writing – original draft, Writing – review & editing

  Affiliation Evidera, Waltham, MA, United States of America

  ⨯
• Beth L. Nordstrom,

  Roles Conceptualization, Formal analysis, Methodology, Project administration, Writing – original draft, Writing – review & editing

  Affiliation Evidera, Waltham, MA, United States of America

  ⨯
• Robert McEwen,

  Roles Conceptualization, Formal analysis, Methodology, Project administration, Writing – original draft, Writing – review & editing

  Affiliation AstraZeneca, Cambridge, United Kingdom

  ⨯
• Todd Hembrough,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation AstraZeneca, Gaithersburg, MD, United States of America

  ⨯
• Naiyer A. Rizvi

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Division of Hematology and Oncology, Columbia University Medical Center, New York, NY, United States of America

  ⨯